Lymphocyte counts may predict a good response to mesenchymal stromal cells therapy in graft versus host disease patients. Hinden L, Avner M, Stepensky P, Or R, et al. PLoS One 2019;14:e0217572.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hinden L, Avner M, Stepensky P, Or R, et al. Lymphocyte counts may predict a good response to mesenchymal stromal cells therapy in graft versus host disease patients. PLoS One 2019;14:e0217572.
PMID: 31188842